| 1 |
35054486 | Overexpression of BQ323636.1 Modulated AR/IL-8/CXCR1 Axis to Confer Tamoxifen Resistance in ER-Positive Breast Cancer. | 2022 Jan 10 |
2 |
| 2 |
33806019 | Targeting the IL-6/STAT3 Signalling Cascade to Reverse Tamoxifen Resistance in Estrogen Receptor Positive Breast Cancer. | 2021 Mar 25 |
1 |
| 3 |
34709749 | KPNA1 regulates nuclear import of NCOR2 splice variant BQ323636.1 to confer tamoxifen resistance in breast cancer. | 2021 Oct |
1 |
| 4 |
32110852 | A Splice Variant of NCOR2, BQ323636.1, Confers Chemoresistance in Breast Cancer by Altering the Activity of NRF2. | 2020 Feb 26 |
1 |
| 5 |
31120927 | Norcantharidin regulates ERα signaling and tamoxifen resistance via targeting miR-873/CDK3 in breast cancer cells. | 2019 |
1 |
| 6 |
29674510 | Tamoxifen Resistance Trumped and Oral Selective Estrogen Receptor Degraders Arrive. | 2018 Aug 1 |
2 |
| 7 |
23117886 | SpliceArray profiling of breast cancer reveals a novel variant of NCOR2/SMRT that is associated with tamoxifen resistance and control of ERα transcriptional activity. | 2013 Jan 1 |
8 |
| 8 |
22249258 | Targeting of the adaptor protein Tab2 as a novel approach to revert tamoxifen resistance in breast cancer cells. | 2012 Oct 4 |
2 |
| 9 |
23015261 | Elevated nuclear expression of the SMRT corepressor in breast cancer is associated with earlier tumor recurrence. | 2012 Nov |
4 |
| 10 |
19698761 | Identification of novel ER-alpha target genes in breast cancer cells: gene- and cell-selective co-regulator recruitment at target promoters determines the response to 17beta-estradiol and tamoxifen. | 2010 Jan 15 |
1 |
| 11 |
20406620 | Inhibition of MAP kinase promotes the recruitment of corepressor SMRT by tamoxifen-bound estrogen receptor alpha and potentiates tamoxifen action in MCF-7 cells. | 2010 May 28 |
4 |
| 12 |
19269830 | Pinning down HER2-ER crosstalk in SMRT regulation. | 2009 Apr |
2 |
| 13 |
19858209 | G protein pathway suppressor 2 (GPS2) is a transcriptional corepressor important for estrogen receptor alpha-mediated transcriptional regulation. | 2009 Dec 25 |
1 |
| 14 |
18546531 | [Expression of ER alpha and SMRT in apoptosis of breast cancer cells induced by tamoxifen]. | 2008 May |
6 |
| 15 |
18838553 | Cdk2 and Pin1 negatively regulate the transcriptional corepressor SMRT. | 2008 Oct 6 |
1 |
| 16 |
17591692 | The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity. | 2007 Sep |
1 |
| 17 |
17599049 | Estrogen-induced and TAFII30-mediated gene repression by direct recruitment of the estrogen receptor and co-repressors to the core promoter and its reversal by tamoxifen. | 2007 Dec 13 |
1 |
| 18 |
15802375 | Cell cycle progression stimulated by tamoxifen-bound estrogen receptor-alpha and promoter-specific effects in breast cancer cells deficient in N-CoR and SMRT. | 2005 Jun |
6 |
| 19 |
12738788 | Full activation of estrogen receptor alpha activation function-1 induces proliferation of breast cancer cells. | 2003 Jul 18 |
1 |
| 20 |
12145334 | Identification of a negative regulatory surface within estrogen receptor alpha provides evidence in support of a role for corepressors in regulating cellular responses to agonists and antagonists. | 2002 Aug |
4 |
| 21 |
11553641 | The tamoxifen-responsive estrogen receptor alpha mutant D351Y shows reduced tamoxifen-dependent interaction with corepressor complexes. | 2001 Nov 16 |
3 |
| 22 |
11916237 | Inhibition of erbB receptor (HER) tyrosine kinases as a strategy to abrogate antiestrogen resistance in human breast cancer. | 2001 Dec |
1 |
| 23 |
10589759 | Expression of nuclear receptor interacting proteins TIF-1, SUG-1, receptor interacting protein 140, and corepressor SMRT in tamoxifen-resistant breast cancer. | 1999 Nov |
1 |
| 24 |
9171233 | The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT. | 1997 Jun |
1 |